Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: 1  reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women who haven't been diagnosed but are at higher-than-average risk for disease.
Types of paper ICT Express publishes original research papers in English in the fields of ICT convergence, platform technologies, communication networks, and device technologies. ICT Express accepts short-length (up to 4 pages in double columns and additional 2 pages will be allowed with over page charge (100USD/1page)) high-quality, original articles in Latex or Word format. Sample manuscript can be downloaded here.
Subscribe to the icts-newsletter-l mailing list. Ask an ICT-related question. Send an email to icts-feedback@uct.ac.za Follow ICTS tweets about scheduled maintenance, known problems, system changes, project and general information. Follow ICTS_Feedback on Twitter Read ICTS-related articles in the media.Go to the In the media page.CTS uses a number of methods to keep campus informed and, in some instances, you have a choice in what you would like to receive. If you want to... Then you need to... Receive announcements about projects, ICT services, scheduled maintenance slots and known problems that affect large numbers of users on campus.